{'fraction_non_alphanumeric': 0.05708661417322835, 'fraction_numerical': 0.017716535433070866, 'mean_word_length': 5.5256410256410255, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Seroprevalence of GB virus C/hepatitis G virus–RNA and anti‐envelope antibody in high‐risk populations in Taiwan

Abstract Background: GB Virus C (GBV‐C)/hepatitis G virus (HGV) was identified in 1995–1996 as a transfusion‐transmissible virus. The diagnosis of GBV‐C/HGV infection is based on the detection of GBV‐C/HGV‐RNA by using polymerase chain reaction. Recently, an enzyme immunoassay detecting the antibodies to the viral protein, E2 envelope protein (anti‐envelope) of GBV‐C/HGV, has been developed.